Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Net Cash Flow (2024 - 2025)

Carlsmed (CARL) has disclosed Net Cash Flow for 2 consecutive years, with -$29.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 585.52% year-over-year to -$29.6 million, compared with a TTM value of $48.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $45.7 million, up 39.01% over the prior year.
  • Net Cash Flow was -$29.6 million for Q4 2025 at Carlsmed, down from $81.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $81.9 million in Q3 2025 and bottomed at -$29.6 million in Q4 2025.